Across TCGA pan-cancer cohorts, ZFYVE9P1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated ZFYVE9P1 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ZFYVE9P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ZFYVE9P1 expression acts as an unfavorable survival marker, although some lineages such as THCA and UCS show a favorable association.

THCA, KICH, and OV are the cancer types where ZFYVE9P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Median	All	0.996	0.898	.002	57	view →
KICH	OS	Median	II,III,IV	0.155	0.880	<.001	42	view →
OV	DFS	Tertile	III,IV	0.308	0.403	.008	38	view →
CHOL	OS	Tertile	III,IV	0.162	0.915	.004	36	view →
UCS	DFS	Median	IV	0.903	0.505	.033	30	view →
ACC	DFS	Tertile	All	0.111	0.505	.044	24	view →
KIRC	DFS	Median	II,III,IV	0.810	0.557	.006	20	view →
KIRP	OS	Tertile	All	0.809	0.906	.019	19	view →
PCPG	OS	Tertile	All	0.341	0.975	.011	19	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
COAD	DFS	Tertile	II,III,IV	0.647	0.811	.016	18	view →
LGG	DFS	Median	All	0.667	0.782	.001	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration

Same gene, other analysis: ZFYVE9P1 tumor-vs-normal RNA expression · all ZFYVE9P1 data types